New Data Shows Vabysmo Improves Vision with Fewer Treatments

August 04, 2022

Vabysmo is the first injectable bispecific antibody to treat wet age-related macular degeneration and diabetic macular edema. Some recent data suggests that the injections can be administered less often than first indicated with no loss of efficacy.